Benin vs Canada: Access to anti-retroviral drugs, male
Benin
78.0%
in 2024
Canada
78.0%
in 2022
Benin rank
51st
Canada rank
51st
Access to anti-retroviral drugs, male over time
- Benin
- Canada
How they compare
Benin currently reports 78.0% against 78.0% in Canada, a difference of 0.0%.
Across all 23 years both countries report, Canada has been ahead every year.
Benin ranks 51st and Canada ranks 51st of 141 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Benin | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.6% | 32.0% | 28.4% | Canada |
| 2010s | 37.6% | 64.5% | 26.9% | Canada |
| 2020s | 61.0% | 79.0% | 18.0% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Benin or Canada?
- Benin, at 78.0% against 78.0% in Canada as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Benin and Canada?
- 0.0%, with Benin ahead.
- How many years of comparable data are there for Benin and Canada?
- 23 years are reported by both, from 2000 to 2022.
- How do Benin and Canada rank globally for access to anti-retroviral drugs, male?
- Benin ranks 51st and Canada ranks 51st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.